Member Log-in

I forgot my password

Not a Member? Register

Resources

Our resource library is a searchable collection of tools and documents related to various technical areas around the Gavi transition. The library consists of research articles, policy briefs, reports, guidebooks, country data, and other resources pertinent to Gavi transition or immunization programs generally. You can filter the resources by topic, type, or country. Some resources are available to LNCT members only and will require logging in to view.

Resources

Results 1 -10 of 14

DPT3 Vaccine Coverage in Africa Data Visualization

This interactive data visualization maps DPT3 vaccine coverage in African nations in fine-scale, 5×5 kilometer increments, so that health officials nationally and locally can identify gaps in vaccine coverage and target interventions with precision, tailoring health policy decisions at local levels. This visualization was developed as part of the Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000-2016: a spatial and temporal modelling study,

Continued

Mapping Diphtheria-Pertussis-Tetanus Vaccine Coverage in Africa, 2000–2016: A Spatial and Temporal Modelling Study

Background
Routine childhood vaccination is among the most cost-effective, successful public health interventions available. Amid substantial investments to expand vaccine delivery throughout Africa and strengthen administrative reporting systems, most countries still require robust measures of local routine vaccine coverage and changes in geographical inequalities over time.

Methods
This analysis drew from 183 surveys done between 2000 and 2016,

Continued

Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign

Background
In April 2014, a national school-based human papillomavirus (HPV) vaccination program was rolled out in South Africa, targeting Grade 4 girls aged ≥9 years. A bivalent HPV vaccine with a 2-dose (6 months apart) schedule was used. At the request of the National Department of Health (NDoH), an external assessment of the first-dose phase of the vaccination program was conducted to evaluate program coverage and vaccine safety and identify factors that influenced implementation.

Continued

The Role of National Immunisation Technical Advisory Groups (NITAGs) in Strengthening National Vaccine Decision-making: A Comparative Case Study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda

Introduction
Improving evidence informed decision-making in immunization is a global health priority and many low and middle-income countries have established National Immunization Technical Advisory Groups (NITAGs) as independent technical advisory bodies for this purpose. NITAG development and strengthening has received financial and technical support over the past decade, but relatively little evaluation.

Continued

NITAG Resource Center

The NITAG Resource Center provides essential documents needed for NITAG establishment, strengthening, and evaluation. Use the interactive map to see each country’s NITAG status, the media center to easily search for guidelines, reports, training, or scientific publications, and the news and events to explore upcoming events relevant for NITAG members.

The platform  was created AMP’s Health Policy and Institutional Development (HPID) unit—which was designated a World Health Organization Collaborating Centre (WHO CC) for evidence-informed immunization policy-making.

Continued

WHO/UNICEF Estimates of National Immunization Coverage

WHO and UNICEF reviewed available data submitted to the organizations and grey papers to make individual country estimates of immunization coverage.

Estimates were made for BCG, the first and third doses of diphtheria and tetanus toxoid and pertussis containing vaccine (DTP1 and DTP3), the third dose of polio containing vaccine – either oral polio vaccine or inactivated polio vaccine (Pol3) –

Continued

New Vaccine Adoption in Lower-middle-income Countries

Lower-middle-income countries (LMICs) are lagging behind both high-income and low-income countries in new vaccine adoption. This study involved the following objectives: (1) understand the decision-making processes of LMICs on new vaccine adoption, (2) identify the factors influencing LMIC decisions, (3) obtain the views of vaccine manufacturers about LMIC markets for new vaccines, and (4) make recommendations concerning how to speed up and improve decision making, including proposing mechanisms for implementation of the recommendations,

Sustaining GAVI-supported Vaccine Introductions in Resource-poor Countries

Since 2000, GAVI provided essential support for an unprecedented increase in the use of hepatitis B (HepB) and Haemophilus influenzae (Hib) containing vaccines in resource poor countries. This increase was supported with significant funding from international donors, intended to be time-limited. To assess the sustainability of this important expansion of the global access to vaccines, the authors of this article reviewed supply chains, financial resources for procurement and decision-making in countries that introduced hepatitis B or Hib vaccines with GAVI support.

Choose a Language